As of 2025-11-03, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is 0.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 133.02 mil USD. AVITA's TTM EBITDA according to its financial statements is 185.83 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 15.1x | 15.1x |
| Forward P/E multiples | 20.4x - 43.0x | 31.7x |
| Fair Price | 104.28 - 299.04 | 162.22 |
| Upside | 2594.6% - 7627.2% | 4091.8% |
| Date | EV/EBITDA |
| 2025-10-31 | 0.72 |
| 2025-10-30 | 0.69 |
| 2025-10-29 | 0.69 |
| 2025-10-28 | 0.69 |
| 2025-10-27 | 0.70 |
| 2025-10-24 | 0.73 |
| 2025-10-23 | 0.74 |
| 2025-10-22 | 0.73 |
| 2025-10-21 | 0.75 |
| 2025-10-20 | 0.74 |
| 2025-10-17 | 0.73 |
| 2025-10-16 | 0.93 |
| 2025-10-15 | 0.92 |
| 2025-10-14 | 0.92 |
| 2025-10-13 | 0.91 |
| 2025-10-10 | 0.90 |
| 2025-10-09 | 0.95 |
| 2025-10-08 | 0.95 |
| 2025-10-07 | 0.95 |
| 2025-10-06 | 0.95 |
| 2025-10-03 | 0.96 |
| 2025-10-02 | 0.95 |
| 2025-10-01 | 0.91 |
| 2025-09-30 | 0.89 |
| 2025-09-29 | 0.93 |
| 2025-09-26 | 0.91 |
| 2025-09-25 | 0.92 |
| 2025-09-24 | 0.91 |
| 2025-09-23 | 0.94 |
| 2025-09-22 | 1.01 |
| 2025-09-19 | 0.95 |
| 2025-09-18 | 0.96 |
| 2025-09-17 | 1.00 |
| 2025-09-16 | 1.06 |
| 2025-09-15 | 1.13 |
| 2025-09-12 | 0.81 |
| 2025-09-11 | 0.79 |
| 2025-09-10 | 0.76 |
| 2025-09-09 | 0.76 |
| 2025-09-08 | 0.76 |
| 2025-09-05 | 0.77 |
| 2025-09-04 | 0.78 |
| 2025-09-03 | 0.78 |
| 2025-09-02 | 0.78 |
| 2025-08-29 | 0.78 |
| 2025-08-28 | 0.79 |
| 2025-08-27 | 0.81 |
| 2025-08-26 | 0.81 |
| 2025-08-25 | 0.83 |
| 2025-08-22 | 0.86 |